"Measuring cells" .. New hope in the war on cancer



[ad_1]
<div id = "firstBodyDiv" data-bind-html-content-type = "article" data-bind-html-compile = "article.body" data-first-article-body = "

The researchers conducted studies on the survival of some living cancer cells and did not die with drugs.

The researchers said the method is to test the weight of the cancer cell and measure the rate of growth, noting that it will reveal whether the drug that the patient is effective or not, "Xinhua reported."

According to the lead author of the study, Shlick, professor of chemistry at the Mbadachusetts Institute of Technology "By measuring cell mbad and growth rate, you can find out whether you answer the drug or not."

Researchers at the institute had already invented a technique to measure cell mbad and growth rates by weighing them frequently over short periods.

"Said Scott Mbades, professor of biological engineering at the same institute" We used this technique to determine the response of anticancer drugs to patients with multiple myeloma, a type of leukemia ".

The researchers found that some cells actually react to the drug, while others resist it. They currently plan to find out if they can be targeted "Resistance Cells" with new drugs.

">

The researchers conducted studies on the survival of some living cancer cells and did not die with drugs.

The researchers said the method was to test the weight of the cancer cell and measure the rate of growth, noting that it would reveal whether the drug that the patient is effective or not, as cited. "Xinhua" agency.

According to the lead author of the study, "By measuring cell mbad and its growth rate, we can see whether or not they respond to the drug," said Schlick, professor of chemistry in Mbadachusetts. Institute of Technology.

Researchers at the institute had already invented a technique to measure cell mbad and growth rates by weighing them frequently over short periods.

"We used this technique to see how anti-cancer drugs respond to patients with multiple myeloma, a type of leukemia," said Scott Mbades, professor of bioengineering at the institute.

The researchers found that some cells actually react to the drug, while others resist it. They currently plan to discover that these "resistance cells" can be targeted by new drugs.

[ad_2]
Source link